Roberts D T, Cox N H, Gentles J C, Babu K K
Department of Dermatology, Western Infirmary, Glasgow, U.K.
J Med Vet Mycol. 1987 Oct;25(5):347-50. doi: 10.1080/02681218780000421.
Twenty-nine patients with mycologically proven tinea pedis were randomly allocated to oral treatment with either ketoconazole 200 mg daily or griseofulvin 1 g daily for a period of up to 8 weeks. Mycological cure rate at 4 weeks was 33% for ketoconazole and 29% for griseofulvin, and at 8 weeks was 53% and 57% respectively. The efficacy of both drugs in the treatment of interdigital tinea pedis is similar, and is considerably lower than that found with topical imidazole preparations where cure rates of over 70% are generally expected.
29例经真菌学证实的足癣患者被随机分配接受口服治疗,一组每日服用200毫克酮康唑,另一组每日服用1克灰黄霉素,疗程最长8周。酮康唑组4周时的真菌学治愈率为33%,灰黄霉素组为29%;8周时,酮康唑组和灰黄霉素组的治愈率分别为53%和57%。两种药物治疗趾间足癣的疗效相似,且显著低于局部用咪唑类制剂,后者通常预期治愈率超过70%。